daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, moxodil
Moxodil, Moxonidine 0.2 mg, Moxonidine, Moxodil-0.2, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, moxodil
daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, moxodil
Moxodil, Moxonidine 0.2 mg, Moxonidine, Moxodil-0.2, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, moxodil

MOXODIL

TAB MOXODIL 0.2 (Moxonidine 0.2 mg ) ALU-ALU 10 X 10
TAB MOXODIL 0.3 (Moxonidine 0.3 mg ) ALU-ALU 10 X 10
Category: Tag:
Send Enquiry

Introduction:

MOXODIL tablets contain Moxonidine, a centrally acting antihypertensive agent primarily used in the treatment of essential hypertension. It works by stimulating imidazoline receptors, leading to a reduction in peripheral vascular resistance and blood pressure without significantly affecting heart rate or cardiac output.

Available in ALU-ALU packaging (10 x 10 tablets) to ensure protection from moisture and extended shelf-life.

Product Variants & Composition:

TAB MOXODIL 0.2
Composition: Moxonidine 0.2 mg
Packaging: ALU-ALU | 10 x 10 Tablets

TAB MOXODIL 0.3
Composition: Moxonidine 0.3 mg
Packaging: ALU-ALU | 10 x 10 Tablets

Key Benefits:

  • Highly effective in lowering blood pressure with minimal side effects.

  • Selective imidazoline receptor agonist, offering better tolerability compared to traditional central sympatholytics (like clonidine).

  • Suitable for monotherapy or combination therapy in mild to moderate hypertension.

  • Does not cause rebound hypertension upon withdrawal (unlike clonidine).

  • Favorable metabolic profile: does not adversely affect lipid or glucose metabolism, ideal for hypertensive patients with metabolic syndrome or diabetes.

Indications:

  • Mild to moderate essential hypertension

  • Resistant hypertension (as part of combination therapy)

  • Hypertensive patients with metabolic comorbidities

Dosage & Administration:

  • Initial dose: Moxonidine 0.2 mg once daily, preferably in the morning.

  • Maintenance dose: May be increased to 0.4 mg–0.6 mg daily, divided into two doses (max 0.6 mg/day).

  • Dose titration should be based on patient response and tolerability.

Precautions & Warnings:

  • Use with caution in patients with renal impairment; dose adjustment may be needed.

  • Avoid sudden discontinuation in long-term users.

  • Not recommended for use in pregnant or breastfeeding women without medical advice.

  • May cause sedation or dry mouth in some patients, particularly during the initial phase.

Possible Side Effects:

  • Dry mouth, fatigue, dizziness

  • Headache, insomnia

  • Nausea, abdominal pain (rare)

  • Bradycardia (in high doses or sensitive patients)

Conclusion:

The MOXODIL range provides a modern, well-tolerated solution for hypertension control, especially beneficial in patients with metabolic risk factors. With two dosage options (0.2 mg and 0.3 mg), it allows individualized blood pressure management while maintaining a strong safety profile.

Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.

For more such product information and similar product category Cardiac

You can also contact us  https://diabetes-cardiac.com/contact-us/

Related products